Regulation of immune responses by L-arginine metabolism
- PMID: 16056256
- DOI: 10.1038/nri1668
Regulation of immune responses by L-arginine metabolism
Abstract
L-Arginine is an essential amino acid for birds and young mammals, and it is a conditionally essential amino acid for adult mammals, as it is important in situations in which requirements exceed production, such as pregnancy. Recent findings indicate that increased metabolism of L-arginine by myeloid cells can result in the impairment of lymphocyte responses to antigen during immune responses and tumour growth. Two enzymes that compete for L-arginine as a substrate - arginase and nitric-oxide synthase - are crucial components of this lymphocyte-suppression pathway, and the metabolic products of these enzymes are important moderators of T-cell function. This Review article focuses on the relevance of L-arginine metabolism by myeloid cells for immunity under physiological and pathological conditions.
Similar articles
-
L-arginine metabolism in myeloid cells controls T-lymphocyte functions.Trends Immunol. 2003 Jun;24(6):302-6. doi: 10.1016/s1471-4906(03)00132-7. Trends Immunol. 2003. PMID: 12810105 Review.
-
Role of arginine metabolism in immunity and immunopathology.Immunobiology. 2007;212(9-10):795-812. doi: 10.1016/j.imbio.2007.09.008. Epub 2007 Nov 14. Immunobiology. 2007. PMID: 18086380 Review.
-
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice.J Immunol. 2003 Jan 1;170(1):270-8. doi: 10.4049/jimmunol.170.1.270. J Immunol. 2003. PMID: 12496409
-
Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.J Immunother Cancer. 2017 Dec 19;5(1):101. doi: 10.1186/s40425-017-0308-4. J Immunother Cancer. 2017. PMID: 29254508 Free PMC article.
-
Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity.J Immunol. 2015 Dec 1;195(11):5237-50. doi: 10.4049/jimmunol.1500959. Epub 2015 Oct 21. J Immunol. 2015. PMID: 26491198 Free PMC article.
Cited by
-
Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells.J Immunol. 2015 May 1;194(9):4215-21. doi: 10.4049/jimmunol.1402004. Epub 2015 Mar 30. J Immunol. 2015. PMID: 25825448 Free PMC article.
-
Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-β.Virology. 2016 Dec;499:9-22. doi: 10.1016/j.virol.2016.08.031. Epub 2016 Sep 12. Virology. 2016. PMID: 27632561 Free PMC article.
-
Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer.Cancer Immunol Immunother. 2015 Oct;64(10):1261-70. doi: 10.1007/s00262-015-1737-x. Epub 2015 Jun 28. Cancer Immunol Immunother. 2015. PMID: 26122358 Free PMC article.
-
Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages.Oncoimmunology. 2020 Mar 6;9(1):1731135. doi: 10.1080/2162402X.2020.1731135. eCollection 2020. Oncoimmunology. 2020. PMID: 32923173 Free PMC article.
-
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.Mol Cancer. 2022 Sep 26;21(1):184. doi: 10.1186/s12943-022-01657-y. Mol Cancer. 2022. PMID: 36163047 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
